A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

Clinical trial NCT02078674 · COMPLETED

Trial details

NCT number: NCT02078674
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza (Pandemic)

Start date: 2014-03-01
Primary completion: 2015-07-01
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.